INTERVENTIONALCOMPLETEDNCT04322461
Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population : Pilot Project PARKA
A two months intervention in which two groups of cognitive disorders, Parkinson and Alzheimer's disease, will receive 50g/day of a commercial MCT supplement combined with supervised aerobic exercise 3 times/week. Cognition and ketones will be assess before and after the intervention, along with endocannabinoids plasma concentrations.
Locally preserved from ClinicalTrials.govOpen ClinicalTrials.gov↗last source update 2025-06-03
What this record can show
Protocol only - no registry results posted
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
Study at a glance
- Phase
- NA
- Enrollment
- 14 (ACTUAL)
- Start date
- 2022-05-01
- Sponsor
- Université de Sherbrooke
- Design
- NON RANDOMIZED · PARALLEL · BASIC SCIENCE
- Locations
- 1
- Results record
- Not present in registry snapshot
Parkinson DiseaseAlzheimer DiseaseAlzheimerParkinsonKetonesmedium chain triglyceridescognitionbrain
Linked local records
Related local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Cannabinoids and active compounds
No governed compound link was found.
Medicines
No exact medicine-name link was found.
Interventions
What was registered
DIETARY SUPPLEMENTBetaquik MCT supplement
50g/day divided in 3. Breakfast, lunch and dinner
Eligibility
Population and criteria
- Sex
- ALL
- Minimum age
- 60 Years
- Maximum age
- Not reported
- Healthy volunteers
- Not accepted
Inclusion criteria
- Alzheimer's or parkinson disease diagnostic
- Stable medication associated with the disease
- Able to consent
- Presence of an accompanying person for the first and last visit.
- Ability to read and talk in French
Exclusion criteria
- MMSE \< 20
- MCT or coconut oil supplementation
- Coconut allergy
- Cannabis, THC or CBD consumption
- Excessive alcohol consumption
- Physical activity 3x/week
- Presence of an metallic object in the body
- Impossibility to lay in dorsal decubitus for 40 minutes
- Cardiac disease
- Any uncontrolled disease that could interfer with the project.
primary outcomes
primary measures
Cognition
Time frame: 2 months, evaluation before and after intervention
Measure of cognition with CANTAB
Ketones
Time frame: 2 months, evaluation before and after intervention
Measurement of ketones concentrations
secondary outcomes
secondary measures
Endocannabinoids
Time frame: 2 months, evaluation before and after intervention
Endocannabinoids plasma concentration
Publications
Locally readable linked articles
No exact PMID-linked public article is currently readable locally.
Snapshot provenance
- Snapshot
- e36f1fd0-c55c-4ffe-a73b-015424dba197
- Retrieved
- 11/09/2026, 14:14:37
- SHA-256
- a8b4adfb073cb078d246bf6a544e40d843ed5a8a33ffea116a45829894e802ae